Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin Effects on Monocyte Polarization in T2D
NCT01617824Phase 4Completed
- Sponsor
- Università di Padova
- Start
- Sep 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Università di Padova. Started Sep 2012; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01617824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617824.